Srinivas Raghavan Viswanathan
NIH Rank #4252
- Program Award PI
- R01 Award PI
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12344771Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#4,252
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Srinivas Raghavan Viswanathan as a PI. Multi-PI records show the full award amount for context.
- 1R01CA302918-01A1R01From biology to therapy: mechanism-informed targeting in translocation renal cell carcinoma$737.1Kaward amount
- 5U01CA269505-04U01Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation$507.1Kaward amount
- 5R21CA296230-02R21Targeting the CDK4/6 pathway in MiT/TFE-translocation renal cell carcinoma$208Kaward amount
Award organization
Organizations that administered FY2026 awards listing Srinivas Raghavan Viswanathan as a PI.
FY2026 award administered by Dana-Farber Cancer Institute (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2024$500K Cumulative Linked Award Amount
- 2024$1M Cumulative Linked Award Amount
- 2024Reached Top 50% by Award-Linked RankRanked #8911
- 2025$2M Cumulative Linked Award Amount
- 2025Reached Top 25% by Award-Linked RankRanked #3433
- 2025R01 Award Record
- 2025Program or Center Award Record
- 2026$5M Cumulative Linked Award Amount
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Srinivas Raghavan Viswanathan.